Engineered SIRP Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies

Science - United States
doi 10.1126/science.1238856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for the Advancement of Science (AAAS)

Related search

Novel Antibodies as Anticancer Agents

Oncogene
Cancer ResearchGeneticsMolecular Biology
2007English

Understanding and Circumventing Resistance to Anticancer Monoclonal Antibodies

mAbs
AllergyImmunology
2009English

Immunotherapeutic Clearance of Systemic Amyloid Deposits by Antibodies to Serum Amyloid P Component

Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Internal MedicineMedicine
2016English

Nitrite Reductase Activity in Engineered Azurin Variants

Inorganic Chemistry
Inorganic ChemistryChemistryTheoretical ChemistryPhysical
2016English

Chemokines as Cancer Vaccine Adjuvants

Vaccines
Drug DiscoveryInfectious DiseasesImmunologyPharmacology
2013English

Nitrite Reductase Activity in Engineered Azurin Variants

English

Biosimilarity of Anticancer Monoclonal Antibodies in the Clinic

GaBI Journal
Drug GuidesPharmacy
2014English

Synthetic Ionophores as Non-Resistant Antibiotic Adjuvants

RSC Advances
ChemistryChemical Engineering
2019English

In Vivo Imaging With Antibodies and Engineered Fragments

Molecular Immunology
ImmunologyMolecular Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy